 Jasper Therapeutics Inc NASDAQ: JSPR is trading lower Thursday amid profit taking after the stock rallied roughly 120 on Wednesday. Jasper Therapeutics surged higher Wednesday after Oppenheimer analyst Jay Olson initiated coverage on the stock with an Outperform rating and announced a price target of 21. 